Vivos Therapeutics Ownership | Who Owns Vivos Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Vivos Therapeutics Ownership Summary


Vivos Therapeutics is owned by 1.78% institutional investors, 26.06% insiders, and 72.16% retail investors. Armistice capital is the largest institutional shareholder, holding 10.18% of VVOS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.58% of its assets in Vivos Therapeutics shares.

VVOS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVivos Therapeutics1.78%26.06%72.16%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryMedical Device Stocks35.88%10.92%53.20%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Armistice capital1.12M10.18%$1.32M
Vanguard group304.16K2.77%$617.45K
Connective capital management200.00K2.20%$620.00K
Geode capital management95.54K0.87%$112.74K
Commonwealth equity services42.50K0.39%$50.15K
Iht wealth management41.06K0.37%$48.45K
B. riley wealth advisors38.07K0.35%$41.49K
Centurion wealth management35.68K0.33%$42.11K
Vanguard fiduciary trust30.83K0.28%$36.38K
Blackrock funding, inc. /de27.82K0.25%$32.82K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Connective capital management200.00K0.57%$620.00K
Armistice capital1.12M0.02%$1.32M
Centurion wealth management35.68K0.01%$42.11K
Acorn wealth advisors14.78K0.01%$17.44K
B. riley wealth advisors38.07K0.00%$41.49K
Iht wealth management41.06K0.00%$48.45K
Xtx topco25.12K0.00%$29.64K
Sequoia financial advisors24.00K0.00%$28.32K
Tower research capital llc (trc)7.39K0.00%$8.72K
Commonwealth equity services42.50K0.00%$50.15K

Top Buyers

HolderShares% AssetsChange
Armistice capital1.12M0.02%1.12M
Vanguard group304.16K-212.70K
Connective capital management200.00K0.57%200.00K
Iht wealth management41.06K0.00%41.06K
Geode capital management95.54K-39.26K

Top Sellers

HolderShares% AssetsChange
Anson funds management lp---242.58K
Drw securities---115.91K
Strategic wealth investment group---100.00K
Renaissance---39.28K
Envestnet asset management---38.87K

New Positions

HolderShares% AssetsChangeValue
Armistice capital1.12M0.02%1.12M$1.32M
Connective capital management200.00K0.57%200.00K$620.00K
Iht wealth management41.06K0.00%41.06K$48.45K
Centurion wealth management35.68K0.01%35.68K$42.11K
Vanguard fiduciary trust30.83K-30.83K$36.38K

Sold Out

HolderChange
Steward partners investment advisory-8.00
Global retirement partners-23.00
Raymond james financial-74.00
Group one trading-228.00
Ewa-10.46K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202612-33.33%194,649-70.42%14.93%4-42.86%2-33.33%
Dec 31, 202513-40.91%597,811-12.95%59.55%5-54.55%2-50.00%
Sep 30, 20252011.11%486,67821.04%524.47%10-4300.00%
Jun 30, 202517-15.00%401,289-23.45%412.55%9-25.00%1-
Mar 31, 2025205.26%524,22012.11%69.68%12100.00%1-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv212.70K1.58%-
Vanguard Institutional Extnd Mkt Idx Tr60.63K0.45%-
Fidelity Extended Market Index60.99K0.45%29.16K
Extended Equity Market Fund B27.82K0.27%-
Extended Equity Market Fund E27.82K0.27%-
Extended Equity Market Fund K23.68K0.23%-174.00
Blackrock Extended Mkt Fund CF27.82K0.21%-
Abante Quant Value FI26.77K0.20%-
BlackRock Extended Equity Market Fund K23.68K0.18%-174.00
Spartan Extended Market Index Pool E6.21K0.11%242.00

Recent Insider Transactions


DateNameRoleActivityValue
Mar 31, 2026Skaff Michael C-Buy$1.40M
Mar 31, 2026Skaff Michael C-Buy$413.86K
Mar 31, 2026Skaff Michael C-Buy$1.94M
Mar 31, 2026Skaff Michael C-Buy$1.94M
Mar 31, 2026Skaff Michael C-Buy$43.00

Insider Transactions Trends


DateBuySell
2026 Q15-
2025 Q2--
2024 Q4--
2024 Q2--
2023 Q25-

VVOS Ownership FAQ


Who Owns Vivos Therapeutics?

Vivos Therapeutics shareholders are primarily institutional investors at 1.78%, followed by 26.06% insiders and 72.16% retail investors. The average institutional ownership in Vivos Therapeutics's industry, Medical Device Stocks, is 35.88%, which Vivos Therapeutics falls below.

Who owns the most shares of Vivos Therapeutics?

Vivos Therapeutics’s largest shareholders are Armistice capital (1.12M shares, 10.18%), Vanguard group (304.16K shares, 2.77%), and Connective capital management (200K shares, 2.20%). Together, they hold 15.15% of Vivos Therapeutics’s total shares outstanding.

Does Blackrock own Vivos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Vivos Therapeutics.

Who is Vivos Therapeutics’s biggest shareholder by percentage of total assets invested?

Connective capital management is Vivos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.57% of its assets in 200K Vivos Therapeutics shares, valued at 620K$.

Who is the top mutual fund holder of Vivos Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Vivos Therapeutics shares, with 1.58% of its total shares outstanding invested in 212.7K Vivos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools